Athersys Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.75M

Athersys General Information

Description

Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical development, manufacturing, and manufacturing process development activities. The firm's main product is Multistem cell therapy. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 3201 Carnegie Avenue
  • Cleveland, OH 44115
  • United States
+1 (216)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Parent Company
Corporate Office
  • 3201 Carnegie Avenue
  • Cleveland, OH 44115
  • United States
+1 (216)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Athersys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Merger/Acquisition 04-Apr-2024 $1.75M Completed Generating Revenue
16. Bankruptcy: Admin/Reorg 05-Jan-2024 Completed Bankruptcy: Admin/Reorg
15. 2PO 21-Aug-2023 Completed Generating Revenue
14. PIPE 10-Nov-2022 Completed Generating Revenue
13. 2PO 17-Apr-2020 Completed Generating Revenue
12. PIPE 30-Apr-2018 Completed Generating Revenue
11. 2PO 27-Jan-2017 Completed Generating Revenue
10. Secondary Transaction - Open Market 15-Jan-2014 Completed Generating Revenue
9. PIPE 26-Oct-2012 $23M $32M Completed Generating Revenue
8. PIPE 22-Mar-2012 $9M $9M Completed Generating Revenue
To view Athersys’s complete valuation and funding history, request access »

Athersys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical
Biotechnology
Cleveland, OH
24 As of 2022

Burlington, MA
 

Montreal, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Athersys Competitors (49)

One of Athersys’s 49 competitors is Vericel, a Formerly PE-Backed company based in Burlington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vericel Formerly PE-Backed Burlington, MA
Kainova Therapeutics Venture Capital-Backed Montreal, Canada
Lineage Cell Therapeutics Corporation Carlsbad, CA
Novavax Corporation Gaithersburg, MD
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
You’re viewing 5 of 49 competitors. Get the full list »

Athersys Patents

Athersys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260224441-A1 Cryostorage devices and methods Pending 16-Jan-2023
WO-2024155498-A1 Cryostorage devices and methods Inactive 16-Jan-2023
WO-2023081420-A1 Culture-expanded canine progenitor cells and related methods Inactive 05-Nov-2021
CA-3176381-A1 Treatment of virus-induced acute respiratory distress syndrome Pending 23-Apr-2020
WO-2021217098-A1 Treatment of virus-induced acute respiratory distress syndrome Inactive 23-Apr-2020 A61K35/545
To view Athersys’s complete patent history, request access »

Athersys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Athersys Former Investors (39)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accipiter Capital Management Hedge Fund Minority
BTHC VI Special Purpose Acquisition Company (SPAC) Minority
BVF Partners Hedge Fund Minority
Blue Chip Venture Company Venture Capital Minority
Chelsey Capital Hedge Fund Minority
You’re viewing 5 of 39 investors. Get the full list »

Athersys Acquisitions (1)

Athersys’s most recent deal was a Merger/Acquisition with BTHC VI. The deal was made on 08-Jun-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BTHC VI 08-Jun-2007 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view Athersys’s complete acquisitions history, request access »

Athersys ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Athersys’s complete esg history, request access »

Athersys FAQs

  • When was Athersys founded?

    Athersys was founded in 1995.

  • Where is Athersys headquartered?

    Athersys is headquartered in Cleveland, OH.

  • What is the size of Athersys?

    Athersys has 24 total employees.

  • What industry is Athersys in?

    Athersys’s primary industry is Biotechnology.

  • Is Athersys a private or public company?

    Athersys is a Private company.

  • What is the current valuation of Athersys?

    The current valuation of Athersys is .

  • What is Athersys’s current revenue?

    The current revenue for Athersys is .

  • How much funding has Athersys raised over time?

    Athersys has raised $2.25M.

  • Who are Athersys’s investors?

    Accipiter Capital Management, BTHC VI, BVF Partners, Blue Chip Venture Company, and Chelsey Capital are 5 of 39 investors who have invested in Athersys.

  • Who are Athersys’s competitors?

    Vericel, Kainova Therapeutics, Lineage Cell Therapeutics, Novavax, and Alnylam Pharmaceuticals are some of the 49 competitors of Athersys.

  • When was Athersys acquired?

    Athersys was acquired on 04-Apr-2024.

  • Who acquired Athersys?

    Athersys was acquired by Healios (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process